Towards the Prediction of Responses to Cancer Immunotherapy: A Multi-Omics Review
Tumor treatment has undergone revolutionary changes with the development of immunotherapy, especially immune checkpoint inhibitors. Because not all patients respond positively to immune therapeutic agents, and severe immune-related adverse events (irAEs) are frequently observed, the development of t...
Saved in:
| Main Authors: | Weichu Tao, Qian Sun, Bingxiang Xu, Ru Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/15/2/283 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mapping the rapid growth of multi-omics in tumor immunotherapy: Bibliometric evidence of technology convergence and paradigm shifts
by: Huijing Dong, et al.
Published: (2025-12-01) -
Integrating multi-omics data to optimize immunotherapy in endometrial cancer: a comprehensive study
by: Xin Guan, et al.
Published: (2025-06-01) -
Editorial: Multi-omics application in exploring potential biomarkers targeting resistance of anti-cancer drugs
by: Huan Wang, et al.
Published: (2025-04-01) -
Contemporary Update on Clinical and Experimental Prostate Cancer Biomarkers: A Multi-Omics-Focused Approach to Detection and Risk Stratification
by: Sana Hachem, et al.
Published: (2024-09-01) -
Meta-analysis of multi-center transcriptomic profiles and machine learning reveal phospholipase Cβ4 as a Wnt/Ca²+ signaling mediator in glioblastoma immunotherapy
by: Zhaoming Song, et al.
Published: (2025-08-01)